About NSB
Under the ticker NSB, Neuroscientific Biopharmaceuticals Ltd operates in the Health Care category and is a biotechnology business centred on the development of novel therapeutics targeting immune-mediated inflammatory disorders. The Company's research is centred on modulating pathological immune responses involved in chronic and degenerative conditions, where current therapeutic options demonstrate limited efficacy or durability. NSB applies advanced preclinical and translational strategies to support the development of biologics addressing unmet clinical need.
All News for NSB
No news articles found for NSB yet.